CLL Tool
Expert Guidance for the Treatment of CLL

Released: August 20, 2024

Expiration: August 19, 2025

Instructions

This Interactive Decision Support Tool provides treatment recommendations based on specific characteristics of your patient. It is recommended that you have as much information as possible about your patient available before you begin. You will be prompted to provide specific factors such as cytogenetics, patient age and fitness, treatment history, and specific comorbidities, such as renal and hepatic dysfunction and cardiac arrhythmias.

Click on your selections. Your choices can be changed at any time simply by reviewing your saved answers, clicking on the [Change] link by your current answer, and selecting a new choice.

Additional information on each variable/characteristic and why it is important for making management selections is available by clicking on the [i] icon after each selection.

When all patient characteristics are entered, you will be asked to select the management option you currently plan. Once that information is entered, you can click the Submit Case button to view the expert recommendations.

After reviewing your case-specific recommendations, you will be asked brief questions about how the recommendations influenced your decision-making. You will then be able to enter a new case scenario by clicking the Start New Case button.

Additional sections that appear in the Table of Contents menu provide more information about this tool: About This Tool, Instructions, Disclaimer, and References.

When viewing the tool on the CCO website, you will also have the following options:

  • Print/download the recommendations along with a summary of the patient characteristics and selected therapy you entered by clicking the Case Summary button.

Access to and use of this Interactive Decision Support Tool titled, “Expert Guidance for the Treatment of CLL” is provided subject to the following terms and conditions. PLEASE READ THESE TERMS CAREFULLY.

This Interactive Decision Support Tool is designed to educate healthcare professionals on making optimal management choices for treating patients with CLL. The information provided is based on expert guidance from Farrukh T. Awan, MD, MS, MBA; Jennifer R. Brown, MD, PhD; Nicole Lamanna, MD; Sameer A. Parikh, MBBS; and Jennifer A. Woyach, MD.

The material published by Clinical Care Options reflects the views of the reviewers or authors of the material, not those of Clinical Care Options, LLC, the accredited provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the FDA. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.

Although the information contained in the “Expert Guidance for the Treatment of CLL” Interactive Decision Support Tool has been produced and processed from sources believed to be reliable, no warranty, expressed or implied, is made regarding the accuracy, adequacy, completeness, legality, reliability, or usefulness of any information. This disclaimer applies to both the isolated and aggregate uses of the information. Clinical Care Options provides this information on an as-is basis. This disclaimer applies to all material published by Clinical Care Options including but not limited to medical information or opinions. All warranties of any kind, expressed or implied, including but not limited to the implied warranties of merchantability, fitness for a particular purpose, freedom from contamination by computer viruses, and noninfringement of proprietary rights are disclaimed.

Any trademarks are the property of respective companies.

© 2024 Clinical Care Options, LLC. All rights reserved.

Program Content